Renowned French Physician Discussed Important Contraindications Of Treating Thoracic Aortic Aneurysms (TAA) By Endografts
Main Category: Cardiovascular / CardiologyArticle Date: 24 Nov 2008 - 9:00 PDT
| Patient / Public: | ![]() | |
| Healthcare Prof: | ![]() |
Endovascular exclusion of complex aortic aneurysms with fenestrated and branched endografts is now routinely performed in many centers.
Dr. Stephan Haulon, M.D., Professor at the Université de Lille, Hôpital Cardiologique-CHRU, Lille, France, outlined a number of important contraindications to this procedure.
First, since there is not long term data available to support its use in young and/or healthy patients, these patients should not be offered this procedure.
Second, even though the endovascular approach is minimally invasive compared to open surgery (absence of aortic cross clamping, laparotomy and thoracotomy), the inability to reimplant intercostal arteries is a major concern as this can result in paraplegia especially in the setting where collateral flow is poor.
Third, patients with chronic dissections and the development of thoracoabdominal aneurysmal dilation are frequently poor candidates for an endovascular approach.
Fourth, and this may change with time, patients with aortic rupture or other complications requiring emergent operation are not candidates for a fenestrated endograft since it takes 6 to 8 weeks to manufacture the specific endograft.
As Dr. Haulon pointed out, future developments include the design of branched and fenestrated endografts that will adapt to a large majority of anatomical features and facilitate repair in a larger group of patients.
VEITH SYMPOSIUM - New York, November 19th to 23rd
Now in its fourth decade, VEITH SYMPOSIUM provides vascular surgeons, interventional radiologists, interventional cardiologists and other vascular specialists with a unique and exciting format to learn the most current information about what is new and important in the treatment of vascular disease. The 5-day event features rapid-fire presentations from world renowned vascular specialists with emphasis on the latest advances, changing concepts in diagnosis and management, pressing controversies and new techniques.
VEITHsymposium is sponsored by Cleveland Clinic, Cleveland, OH.
www.veithsymposium.org
Source
Pauline T. Mayer
www.ptmhcm.com
Visit our cardiovascular / cardiology section for the latest news on this subject.
MLA
13 Feb. 2012. <http://www.medicalnewstoday.com/releases/130522.php>
APA
http://www.medicalnewstoday.com/releases/130522.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.




